Acquiring hepatitis C in prison: the social organisation of injecting risk

Por Treloar, Carla, McCredie, Luke, Lloyd, Andrew R
Publicado no Harm Reduct J (2015)

The Prison Economy of Needles and Syringes: What Opportunities Exist for Blood Borne Virus Risk Reduction When Prices Are so High?

Por Treloar, Carla, McCredie, Luke, Lloyd, Andrew R.
Publicado no PLoS One (2016)

Gene Expression in Response to Exercise in Patients with Chronic Fatigue Syndrome: A Pilot Study

Por Keech, Andrew, Vollmer-Conna, Ute, Barry, Benjamin K., Lloyd, Andrew R.
Publicado no Front Physiol (2016)

Inhibitors of the Hepatitis C Virus Polymerase; Mode of Action and Resistance

Por Eltahla, Auda A., Luciani, Fabio, White, Peter A., Lloyd, Andrew R., Bull, Rowena A.
Publicado no Viruses (2015)

If I Am in the Mood, I Enjoy It: An Exploration of Cancer-Related Fatigue and Sexual Functioning in Women with Breast Cancer

Por Webber, Kate, Mok, Kelly, Bennett, Barbara, Lloyd, Andrew R., Friedlander, Michael, Juraskova, Ilona, Goldstein, David
Publicado em 2011

Per-Event Probability of Hepatitis C Infection during Sharing of Injecting Equipment

Por Boelen, Lies, Teutsch, Suzy, Wilson, David P., Dolan, Kate, Dore, Greg J., Lloyd, Andrew R., Luciani, Fabio
Publicado em 2014

Transmission of Hepatitis C Virus among Prisoners, Australia, 2005–2012

Por Bretaña, Neil Arvin, Boelen, Lies, Bull, Rowena, Teutsch, Suzy, White, Peter A., Lloyd, Andrew R., Luciani, Fabio
Publicado no Emerg Infect Dis (2015)

Incident Hepatitis C Virus Genotype Distribution and Multiple Infection in Australian Prisons

Por Walker, Melanie R., Li, Hui, Teutsch, Suzy, Betz-Stablein, Brigid, Luciani, Fabio, Lloyd, Andrew R., Bull, Rowena A.
Publicado no J Clin Microbiol (2016)

Quantification of Hepatitis C Virus in Human Liver and Serum Samples by Using LightCycler Reverse Transcriptase PCR

Por White, Peter A., Pan, Yong, Freeman, Anthony J., Marinos, George, Ffrench, Rosemary A., Lloyd, Andrew R., Rawlinson, William D.
Publicado em 2002

Risk factors for hepatitis C infection and perception of antibody status among male prison inmates in the hepatitis C incidence and transmission in prisons study cohort, Australia

Por Gates, Jennifer A., Post, Jeffrey J., Kaldor, John M., Pan, Yong, Haber, Paul S., Lloyd, Andrew R., Dolan, Kate A.
Publicado em 2004

Transmitted/Founder Viruses Rapidly Escape from CD8(+) T Cell Responses in Acute Hepatitis C Virus Infection

Por Bull, Rowena A., Leung, Preston, Gaudieri, Silvana, Deshpande, Pooja, Cameron, Barbara, Walker, Melanie, Chopra, Abha, Lloyd, Andrew R., Luciani, Fabio
Publicado no J Virol (2015)

Hepatitis C virus clearance, reinfection, and persistence, with insights from studies of injecting drug users: towards a vaccine

Por Grebely, Jason, Prins, Maria, Hellard, Margaret, Cox, Andrea L, Osburn, William O, Lauer, Georg, Page, Kimberly, Lloyd, Andrew R, Dore, Gregory J
Publicado em 2012

The Interferon-induced Transmembrane Proteins, IFITM1, IFITM2, and IFITM3 Inhibit Hepatitis C Virus Entry

Por Narayana, Sumudu K., Helbig, Karla J., McCartney, Erin M., Eyre, Nicholas S., Bull, Rowena A., Eltahla, Auda, Lloyd, Andrew R., Beard, Michael R.
Publicado no J Biol Chem (2015)

Dynamic evolution of hepatitis C virus resistance-associated substitutions in the absence of antiviral treatment

Por Eltahla, Auda A., Leung, Preston, Pirozyan, Mehdi R., Rodrigo, Chaturaka, Grebely, Jason, Applegate, Tanya, Maher, Lisa, Luciani, Fabio, Lloyd, Andrew R., Bull, Rowena A.
Publicado no Sci Rep (2017)

Maintenance of Th1 HCV-specific responses in individuals with acute HCV who achieve sustained virological clearance after treatment

Por Flynn, Jacqueline K, Dore, Gregory J, Hellard, Margaret, Yeung, Barbara, Rawlinson, William D, White, Peter A, Kaldor, John M, Lloyd, Andrew R, Ffrench, Rosemary A
Publicado em 2013

Early IL-10 predominant responses are associated with progression to chronic hepatitis C virus infection in injecting drug users

Por Flynn, Jacqueline K, Dore, Gregory J, Hellard, Margaret, Yeung, Barbara, Rawlinson, William D, White, Peter A, Kaldor, John M, Lloyd, Andrew R, Ffrench, Rosemary A
Publicado no J Viral Hepat (2010)

Sequential Bottlenecks Drive Viral Evolution in Early Acute Hepatitis C Virus Infection

Por Bull, Rowena A., Luciani, Fabio, McElroy, Kerensa, Gaudieri, Silvana, Pham, Son T., Chopra, Abha, Cameron, Barbara, Maher, Lisa, Dore, Gregory J., White, Peter A., Lloyd, Andrew R.
Publicado em 2011

Impaired Hepatitis C Virus (HCV)–Specific Interferon-γ Responses in Individuals With HIV Who Acquire HCV Infection: Correlation With CD4(+) T-Cell Counts

Por Flynn, Jacqueline K., Dore, Gregory J., Matthews, Gail, Hellard, Margaret, Yeung, Barbara, Rawlinson, William D., White, Peter A., Kaldor, John M., Lloyd, Andrew R., Ffrench, Rosemary A.
Publicado em 2012

HIV and co-infections

Por Chang, Christina C, Crane, Megan, Zhou, JingLing, Mina, Michael, Post, Jeffrey J, Cameron, Barbara A, Lloyd, Andrew R, Jaworowski, Anthony, French, Martyn A, Lewin, Sharon R
Publicado em 2013

Alanine aminotransferase, HCV RNA levels and pro-inflammatory and pro-fibrogenic cytokines/chemokines during acute hepatitis C virus infection

Por Hajarizadeh, Behzad, Lamoury, François MJ, Feld, Jordan J., Amin, Janaki, Keoshkerian, Elizabeth, Matthews, Gail V., Hellard, Margaret, Dore, Gregory J., Lloyd, Andrew R., Grebely, Jason, Applegate, Tanya L.
Publicado no Virol J (2016)